Thrivent Financial for Lutherans’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Sell	77,119 -2,270	-3%	-$54.1K	﹤0.01%	1498
2025 Q4	$1.85M	Sell	79,389 -3,610	-4%	-$80.4K	﹤0.01%	1543
2025 Q3	$1.64M	Sell	82,999 -1,310	-2%	-$26.9K	﹤0.01%	1465
2025 Q2	$1.83M	Buy	84,309 +1,957	+2%	+$46.2K	﹤0.01%	1412
2025 Q1	$2M	Sell	82,352 -4,308	-5%	-$97K	﹤0.01%	1291
2024 Q4	$1.81M	Sell	86,660 -952	-1%	-$20.5K	﹤0.01%	1506
2024 Q3	$1.74M	Sell	87,612 -5,538	-6%	-$103K	﹤0.01%	1539
2024 Q2	$1.44M	Sell	93,150 -3,740	-4%	-$58.2K	﹤0.01%	1615
2024 Q1	$1.54M	Buy	96,890 +7,591	+9%	+$114K	﹤0.01%	1607
2023 Q4	$1.5M	Sell	89,299 -2,353	-3%	-$32.2K	﹤0.01%	1581
2023 Q3	$1.07M	Sell	91,652 -1,618	-2%	-$21.6K	﹤0.01%	1694
2023 Q2	$1.25M	Sell	93,270 -1,615	-2%	-$23.2K	﹤0.01%	1656
2023 Q1	$1.57M	Sell	94,885 -3,326	-3%	-$54.9K	﹤0.01%	1466
2022 Q4	$1.83M	Buy	98,211 +427	+0.4%	+$6.57K	﹤0.01%	1312
2022 Q3	$1.25M	Buy	+97,784	New	+$1.16M	﹤0.01%	1523